This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-08-24 and is reviewed periodically as new material appears.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
NASA achieved the first approach and landing test of its Space Shuttle orbiter on a Boeing 747 carrier plane on August 12, 1977, and the first orbital test flight of a complete, crewed Space Shuttle, consisting of the orbiter, an external fuel tank, and two solid rocket boosters, on April 12, 1981. The designers underestimated the time and cost of refurbishment between flights, which reduced the cost benefit of its reusability. They also overestimated its safety: two of the fleet of five orbiters were lost in fatal flight accidents: one during launch, due to failure of a solid rocket booster seal; and one on reentry, due to launch damage of a wing heat shield. The Air Force was also supposed to use the Shuttle to launch its military payloads, but shunned it in favor of its expendable launchers after the first Shuttle loss. NASA ceased production of its Apollo spacecraft and Saturn IB launcher, and used the Shuttle as its orbital workhorse until 2011, then retired it due to the safety concern. Originally, more than 150 flights over a 15-year operation were expected; actually, the Shuttles made 135 flights in the 30-year lifespan of the series. The Soviets interpreted the Shuttle as a military surveillance vehicle, and decided they had to develop their own shuttle, which they named Buran, beginning in 1974. They copied the aerodynamic design of NASA's Shuttle orbiter, which they strapped to the side of their expendable, liquid hydrogen-fueled Energia launcher.
In 2023, his work highlighted that substituted beta oligoamides self-assemble into metallosupramolecular frameworks with varied structures, including thin films and three-dimensional networks, by coordinating with different transition metals and metalates.
The Reconstruction (Greek: Αναπαράσταση, romanized: Anaparastasi) is a 1970 Greek dramatic black and white independent art film directed by Theo Angelopoulos. It is the director's first feature film. While based on true events, it transcends them to recall the ancient myths of the Atrides and Clytemnestra. In 1986, the Greek Film Critics Association named it the third-best Greek film in history.
Sources: en.wikipedia.org
== Localization of pyruvate decarboxylation == In eukaryotic cells the pyruvate decarboxylation occurs inside the mitochondrial matrix, after transport of the substrate, pyruvate, from the cytosol. The transport of pyruvate into the mitochondria is via the transport protein pyruvate translocase. Pyruvate translocase transports pyruvate in a symport fashion with a proton (across the inner mitochondrial membrane), which may be considered to be a form of secondary active transport, but further confirmation/support may be needed for the usage of "secondary active transport" descriptor here (Note: the pyruvate transportation method via the pyruvate translocase appears to be coupled to a proton gradient according to S. Papa et al., 1971, seemingly matching secondary active transport in definition). Alternative sources say "transport of pyruvate across the outer mitochondrial membrane appears to be easily accomplished via large non-selective channels such as voltage-dependent anion channels, which enable passive diffusion" and transport across inner mitochondrial membrane is mediated by mitochondrial pyruvate carrier 1 (MPC1) and mitochondrial pyruvate carrier 2 (MPC2). Upon entry into the mitochondrial matrix, the pyruvate is decarboxylated, producing acetyl-CoA (and carbon dioxide and NADH). This irreversible reaction traps the acetyl-CoA within the mitochondria (the acetyl-CoA can only be transported out of the mitochondrial matrix under conditions of high oxaloacetate via the citrate shuttle, a TCA intermediate that is normally sparse).
Gel electrophoresis is a method for separation and analysis of biomacromolecules (DNA, RNA, proteins, etc.) and their fragments, based on their size and charge as they move through a gel under an electric field. It is used in clinical chemistry to separate proteins by charge or size and in biochemistry and molecular biology to separate a mixed population of DNA and RNA fragments by length, to estimate the size of DNA and RNA fragments, or to separate proteins by charge. Nucleic acid molecules are separated by applying an electric field to move the negatively charged molecules through a gel matrix of agarose, polyacrylamide, or other substances. Shorter molecules move faster and migrate farther than longer ones because shorter molecules flow more easily through the pores of the gel. This phenomenon is called sieving. Proteins are separated by the charge in agarose because the pores of the gel are too large to sieve proteins. Gel electrophoresis can also be used for the separation of nanoparticles. Gel electrophoresis uses a gel as an anticonvective medium or sieving medium during electrophoresis. Gels suppress the thermal convection caused by the application of the electric field and can also serve to maintain the finished separation so that a post-electrophoresis stain can be applied.
==== Physical gels ==== In physical gels unlike covalently linked gels the polymers chains are not covalently linked together. That means that the gel could re-dissolve in a good solvent under some conditions. Thermoresponsive physical gels, also sometimes called thermoresponsive injectable gels have been used in Tissue Engineering. This involves mixing at room temperature the thermoresponsive polymer in solution with the cells and then inject the solution to the body. Due to the temperature increase (to body temperature) the polymer creates a physical gel. Within this physical gel the cells are encapsulated. Tailoring the temperature that the polymer solution gels can be challenging because this depend by many factors like the polymer composition, architecture as well as the molar mass.
== Debonding and loss == In 1953, sociologist Diane Vaughan proposed an uncoupling theory. It states that during the dynamics of relationship breakup, there exists a "turning point," only noted in hindsight, followed by a transition period in which one partner unconsciously knows the relationship is going to end, but holds on to it for an extended period, sometimes for a number of years. When a person to which one has become bonded is lost, a grief response may occur. Grief is the process of accepting the loss and adjusting to the changed situation. Grief may take longer than the initial development of the bond. The grief process varies with culture.
Sources: en.wikipedia.org
==== MeSH D12.125.142 – amino acids, essential ==== MeSH D12.125.142.087 – arginine MeSH D12.125.142.087.500 – omega-n-methylarginine MeSH D12.125.142.308 – histidine MeSH D12.125.142.383 – isoleucine MeSH D12.125.142.441 – leucine MeSH D12.125.142.497 – lysine MeSH D12.125.142.557 – methionine MeSH D12.125.142.666 – phenylalanine MeSH D12.125.142.815 – threonine MeSH D12.125.142.875 – tryptophan MeSH D12.125.142.930 – valine
Has a low tannin content, no caffeine. Horehound Houttuynia Hydrangea tea, dried leaves of hydrangeas; considerable care must be taken because most species contain a toxin. The "safe" hydrangeas belong to the Hydrangea serrata Amacha ("sweet tea") cultivar group. Jasmine flower tea, though it is commonly blended with tea leaves, jasmine flowers are also sometimes infused on their own Jiaogulan (also known as xiancao or "poor man's ginseng") Kapor tea, dried leaves of fireweed Kelp tea, East Asian tea made from kelp, known as konbu-cha in Japan Kuzuyu, a thick white Japanese tea made by adding kudzu flour to hot water Labrador tea, made from the shrub by the same name, found in the northern part of North America Lavender tea Lemon balm Lemon and ginger tea Lemongrass tea Luo han guo Licorice root Lime blossom, dried flowers of the lime tree (tilia in Latin). Meadowsweet herb Mint herbal tea, made from various mints, especially peppermint and spearmint. It is also commonly mixed with green tea, as in Maghrebi mint tea. Korean mint tea is one popular pure mint herbal tea. Mound of termites tea in Merauke Moringa Mountain tea, common in the Balkans and other areas of the Mediterranean region. Made from a variety of the Sideritis syriaca plant which grows in warm climates above 3,000 feet. Records of its use date back 2,000 years. Dried flowers of the Mullein Neem leaf Nettle leaf New Jersey tea (Ceanothus americanus), which has a mild blood pressure lowering effect.
Their subsequent work shows how the SREBP pathway regulates the expression of many genes that control lipid formation and metabolism and body fuel allocation. Cholesterol synthesis can be turned off when cholesterol levels are high. HMG-CoA reductase contains both a cytosolic domain (responsible for its catalytic function) and a membrane domain which senses signals for its degradation. Increasing concentrations of cholesterol (and other sterols) cause a change in this domain's oligomerization state, making it more susceptible to destruction by the proteasome. This enzyme's activity can also be reduced by phosphorylation by an AMP-activated protein kinase. Because this kinase is activated by AMP, which is produced when ATP is hydrolyzed, it follows that cholesterol synthesis is halted when ATP levels are low.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.